Although evidence of cognitive impairment in MSA is admittedly more limited than in Parkinson disease, it is now substantial enough to address modification of diagnostic criteria to include the potential for cognitive impairment at any stage of the disease.
Evaluating the risk factors of neurocognitive decline in HIV.
Findings from animal studies indicate that anesthetics may be neurotoxic and could result in long-term central nervous system alterations and cognitive dysfunction.
Physicians should provide counseling to adolescents on the effects of marijuana.
Mechanisms including silent cerebral infarct, microemboli, microbleedings, and cerebral hypoperfusion may be responsible for the link between atrial fibrillation and cognitive decline.
Individuals with prevalent dementia and any nursing home use had especially high 1-year mortality.
Cognitive dysfunction may be the result of lower intracerebral vasomotor reactivity which is linked to PHPT.
Previous reports have suggested that statins or the low levels of LDL cholesterol they promote may have an adverse impact on cognition.
Findings from this trial challenge current recommended systolic blood pressure targets for older adults.
Visual dysfunction is associated with poor cognitive function in older adults.
Cognitive deficits can be caused by sleep-disordered breathing.
Effective cognitive screening instruments are needed in order to assess and manage milder forms of HIV-associated neurocognitive disorders.
Most patients undergoing skull base irradiation for cancer do not have detectable cognitive impairment.
Reduced intelligence may be linked with developmental exposures to polybrominated diphenyl ethers.
A set of biomarkers is associated with cognition in male professional fighters.
Many residents in nursing homes with cognitive impairments may be taking potentially inappropriate medications.
Light therapy has a moderate effect on behavioral disturbances and depression for people with cognitive impairment.
The researchers found that postoperative delirium occurred in 24% of participants and that 12% had 2 or more delirium days.
Improved cognitive function in older adults is being linked to the Mediterranean diet.
Cognitive dysfunction is 3 times higher in patients with systemic lupus erythematosus.
An intensive lifestyle intervention including diet and exercise resulted in no improvements in cognitive impairment.
Significant benefits were seen with aerobic exercise, resistance training, multicomponent training, and tai chi.
Chronic use of low-dose aspirin was not associated with onset of dementia or cognitive impairment, but was also not associated with significantly better global cognition.
The researchers found that higher baseline HOMA-IR and fasting insulin levels were independent predictors of poorer verbal fluency performance.
Patients with subclinical hypothyroidism scored worse on tests of processing speed than patients with normal thyroid function.
Previous research has suggested that statins and PCSK9 inhibitors may adversely affect cognition.
Middle-aged adults with orthostatic hypotension were found 40% more likely to develop dementia over time.
The study results suggest that patients with non-NPSLE have impaired memory function indicative of working memory-related neural dysfunction.
Engaging in mentally stimulating activities like games, crafting, and computers may help slow cognitive decline in the elderly.
Specific differences were found in the brains of those who attempted suicide and those who did not.
Neurology Advisor Articles
- Coffee Consumption May Decrease Stroke Risk
- Prochlorperazine More Effective Than Ketamine for Headache Relief in the Emergency Department
- CTE Confirmed With Antemortem PET Imaging, Autopsy in Professional Football Player
- Intranasal Sumatriptan More Effectively Reduces Migraine-Associated Nausea
- Neuropsychiatric Conditions Common in Relatives of Patients With Amyotrophic Lateral Sclerosis
- Treating Cluster Headache: Weighing Current Therapies
- Alzheimer Disease Linked to High Cumulative Doses of Zolpidem in Elderly
- NBT System Gets FDA Clearance for Depression Treatment
- Better Migraine Pain Relief With IV Non-Opioid Combination vs IV Hydromorphone
- FDA Approves Myasthenia Gravis Treatment
- Reports of Agranulocytosis Prompt Monitoring for Investigational Parkinson's Drug
- Nusinersen Improves Motor Function, Survival in Infants With Spinal Muscular Atrophy
- Noninvasive Brain Stimulation System Approved for Depression
- Hypertension Guidelines Updated by AHA/ACA
- Bone Mineral Density Associated With Intracranial Aneurysm Presence, Size